Apeiron Investment Group Ltd., 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 4,967 shares at $5.19 ($26K) on 2022-04-14, disclosed to the SEC on 2022-04-18.
Open-market purchase of $26k ATAI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |